ABC / Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. more_horizontal

Walgreens Boots Alliance has sold shares of AmerisourceBergen for initial proceeds of $2.85 billion, which will be used to accelerate the drugstore gi more_horizontal

Walgreens Boots Alliance has sold some AmerisourceBergen Corp's shares for proceeds of about $1.85 billion, the U.S. drugstore chain said on Thursday, more_horizontal

Drugstore chain Walgreens Boots Alliance Inc. WBA, -1.17% on Thursday said it sold shares of drug distributor AmerisourceBergen Corp. ABC, -0.04% for more_horizontal

Although the revenue and EPS for AmerisourceBergen (ABC) give a sense of how its business performed in the quarter ended June 2023, it might be worth more_horizontal

Drug distributor AmerisourceBergen raised its full-year profit forecast on Wednesday, as soaring demand for weight-loss drugs and specialty medicines more_horizontal

AmerisourceBergen has seen a 3x return on investment in the past 3 years, outperforming the market. I think it's a very solid company in pharma and he more_horizontal

AmerisourceBergen's (ABC) fiscal third-quarter 2023 results are likely to reflect solid performance at the U.S. Healthcare Solutions segment. more_horizontal